Sarcopenia Treatment Market Size and Forecasts (2020 – 2030)

Sarcopenia Treatment Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Vitamin D and Calcium Supplements, Protein Supplements, Vitamin B12 Supplements, and Others), Distribution Channel (Pharmacies, Retail Channels, Online Channels, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry
Item ID: TIPRE00010491 Category: Tags: , ,

$3,633$6,433

Description

According to our latest study on “Sarcopenia Treatment Market Forecast to 2030 – Global Analysis – Treatment Type, and Distribution Channel,” the sarcopenia treatment market value is expected to reach US$ 5.264 billion by 2030 from US$ 3.397 billion in 2022. The report highlights trends prevailing in the market and factors driving and hindering the growth of the sarcopenia treatment market.
The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of pathogenicity, target patients, prevention, and treatments, among other aspects, along with underlining the value of prompt diagnosis and treatment. The Office on Women’s Health (OWH) of the US Department of Health and Human Services launched the national campaign “Stronger than Sarcopenia” in 2023 to magnify the awareness of sarcopenia in women. Research by Health and Human Services shows that more than 45% of the elderly population in the US suffers from sarcopenia, and millions of younger individuals are at risk of developing this condition later in their lives. In line with OWH’s “Stronger than Sarcopenia” campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required.
Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. According to a February 2022 PubMed article, the US Department of Health and Human Services is one of the top funding agencies in the US, sponsoring 1,604 studies on sarcopenia. From 2022, July 4 will be observed as World Sarcopenia Day. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years.
The sarcopenia treatment market, by treatment type, is segmented into vitamin D and calcium supplements, protein supplements, vitamin B12 supplements, and others. The vitamin D and calcium supplements segment held the largest share of the market in 2022. The sarcopenia treatment market for this segment is anticipated to record the highest CAGR of 6.5% from 2022 to 2030. Being a fat-soluble vitamin, vitamin D is crucial for maintaining calcium homeostasis and healthy bone metabolism. The supplementation of vitamin D has been studied as a useful dietary strategy to reduce the risk of sarcopenia. Older adults with suboptimal vitamin D levels are highly susceptible to sarcopenia, often associated with falls, hospitalization, and other adverse effects.
The Public Health Agency of Canada, the US Department of Health and Human Services, and NIH are a few key primary and secondary sources referred to while preparing the report on the sarcopenia treatment market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Vitamin D and Calcium Supplement Segment by Treatment Type to Account Larger Share in Sarcopenia Treatment Market during 2022–2030

According to our latest study on ” Sarcopenia Treatment Market Forecast to 2030 – Global Analysis –Treatment Type and Distribution Channel,” the heart transplant market value is expected to reach US$ 5.264 billion by 2030 from US$ 3.397 billion in 2022. The report highlights trends prevailing in the market and factors driving and hindering the growth of the sarcopenia treatment market.

Sarcopenia is the progressive reduction in muscle mass and strength associated with aging. Muscle weakness is the primary sign of the illness. Muscle shrinkage, known as sarcopenia, is mostly brought on by aging naturally. According to scientists, the disease may be exacerbated by an improper diet and a lack of physical activity. Nutritional therapy and exercise therapy are two ways that sarcopenia is treated. For the purpose of improving sarcopenia, a combination of dietary therapy and a thorough exercise regimen, including resistance training, works better than either treatment alone.

Asia Pacific is expected to register the fastest CAGR in the global market between 2022 and 2030. The market growth in this region is ascribed to the rise in healthcare awareness of the importance of organ donation and a surge in social media marketing to encourage a positive attitude toward organ donation. Additionally, advancing healthcare infrastructure and increasing investments to boost manufacturing capacities are projected to drive the Asia Pacific heart transplant market during the forecast period. India has a very low organ donation rate due to the lack of public awareness, religious or superstitious beliefs among people, and strict laws. Organ donation rates in India are ~0.01%, which is a minuscule figure in contrast to countries such as Croatia (36.5%) and Spain (35.3%), which limits the organ preservation market in India. The Government of India implemented the National Organ Transplant Programme in 2019 with a budget of US$ 21,000 (?149.5 crores) for encouraging deceased organ donation. These government initiatives, along with other numerous government and non-government organizations’ initiatives, have scaled up the rate of organ donation in the region. In 2019, 13 of the 36 states, as well as union territories in India reported deceased donations. Most of the deceased donation programs have been exhibited in the Southern states. ~50,000 people require heart transplants annually, but merely 0.2% receive suitable donors; each year, nearly 90–100 transplantations are conducted.

Terumo Corp, LivaNova Plc, Jarvik Heart Inc, BiVACOR Inc, Evaheart Inc, Berlin Heart GmbH, BioVentrix, SynCardia Systems LLC, Calon Cardio-Technology Ltd, and Abbott Laboratories are the prominent heart transplant market players.

Companies operating in the heart transplant market adopt various organic and inorganic strategies. Growth strategies mainly include product launches and product approvals, mergers & acquisitions, collaborations, and partnerships are among the growth strategies witnessed in the heart transplant market.
A few of the significant developments by key market players are listed below.

• In April 2023, Terumo Aortic announced the first North American implant of a novel custom-made hybrid device, Thoracoflo, which is used to treat patients with thoracoabdominal aortic disease using a less invasive surgical technique than traditional open surgical repair.
• In September 2021, the company implemented inorganic growth strategies to reach more customers. The venture capital investment firm Hunniwell Lake Ventures, LLC, with its headquarters in California, acquired SynCardia. As a result, SynCardia now has the operational and financial means to guarantee its continued expansion and success both domestically and internationally. In order to assist more patients, the company has been able to continue creating cutting-edge medical devices and exploring new indications owing to this funding.
• In January 2022, BioVentrix Acquired MateraCor Inc. and its lead product. MateraCor, Inc. is a company that uses injectable hydrogel based on alginate to stop the progression of heart failure and reverse it.
• In June 2021, Abbott Laboratories announced that it has enhanced its capacity and supply for mechanical circulatory support (MCS) devices and Medtronic HeartWare ventricular assist devices (HVAD). In addition, the company announced providing support training and education programs for its HeartMate 3 heart pump.

?

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Colorectal Cancer Diagnostics Market – by Modality
1.3.2 North America Colorectal Cancer Diagnostics Market – by End User
1.3.3 North America Colorectal Cancer Diagnostics Market – by Country
2. North America Colorectal Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Colorectal Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert’s Opinion
5. North America Colorectal Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 Launches of New Products
5.2 Key Restraints
5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
5.3 Opportunities
5.3.1 Growing Awareness of Colorectal Cancer
5.4 Future Trends
5.4.1 Artificial Intelligence in Colonoscopy
5.5 Impact Analysis
6. Colorectal Cancer Diagnostics Market – North America Analysis
6.1 North America Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 North America Colorectal Cancer Diagnostics Market, By Geography – Forecast and Analysis
7. North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by Modality
7.1 Overview
7.2 North America Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
7.3 Stool Based Tests
7.3.1 Overview
7.3.2 Stool Based Tests: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Faecal Immunochemical Test (FIT)
7.3.3.1 Overview
7.3.3.2 Faecal Immunochemical Test (FIT): North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
7.3.4.1 Overview
7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool DNA Test
7.3.5.1 Overview
7.3.5.2 Stool DNA Test: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Colonoscopy
7.4.3.1 Overview
7.4.3.2 Colonoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 CT Colonography
7.4.4.1 Overview
7.4.4.2 CT Colonography: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Flexible Sigmoidoscopy
7.4.5.1 Overview
7.4.5.2 Flexible Sigmoidoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Capsule Endoscopy
7.4.6.1 Overview
7.4.6.2 Capsule Endoscopy: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.7 Others
7.4.7.1 Overview
7.4.7.2 Others: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by End User
8.1 Overview
8.2 North America Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer Research Institutes
8.5.1 Overview
8.5.2 Cancer Research Institutes: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – Country Analysis
9.1 Overview
9.1.1.1 US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.3 US: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.1.3.1 US: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.1.3.2 US: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.1.4 US: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.2 Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.3 Canada: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.2.3.1 Canada: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.2.3.2 Canada: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.2.4 Canada: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.1.3 Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.3 Mexico: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.1.3.3.1 Mexico: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.1.3.3.2 Mexico: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.1.3.4 Mexico: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
10. North America Colorectal Cancer Diagnostics Market–Industry Landscape
10.1 Overview
10.2 Inorganic Growth Strategies
10.2.1 Overview
10.3 Organic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Illumina Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Clinical Genomics Technologies Pty Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 EDP Biotech Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Epigenomics AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 F. Hoffmann-La Roche Ltd
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Quest Diagnostics Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Siemens Healthineers AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Bruker Corp
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Eiken Chemical Co., Ltd.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Million)
Table 4. Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Million) – By Treatment Type
Table 5. Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Million) – By Distribution Channel
Table 6. North America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 7. North America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 8. North America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Country
Table 9. United States Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 10. United States Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 11. Canada Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 12. Canada Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 13. Mexico Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 14. Mexico Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 15. Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 16. Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 17. Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Country
Table 18. Germany Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 19. Germany Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 20. France Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 21. France Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 22. United Kingdom Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 23. United Kingdom Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 24. Italy Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 25. Italy Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 26. Spain Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 27. Spain Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 28. Rest of Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 29. Rest of Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 30. Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 31. Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 32. Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Country
Table 33. China Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 34. China Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 35. India Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 36. India Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 37. Japan Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 38. Japan Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 39. South Korea Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 40. South Korea Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 41. Australia Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 42. Australia Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 43. Rest of APAC Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 44. Rest of APAC Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 45. Middle East and Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 46. Middle East and Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 47. Middle East and Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Country
Table 48. South Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 49. South Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 50. Saudi Arabia Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 51. Saudi Arabia Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 52. United Arab Emirates Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 53. United Arab Emirates Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 54. Rest of Middle East and Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 55. Rest of Middle East and Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 56. South and Central America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 57. South and Central America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 58. South and Central America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Country
Table 59. Brazil Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 60. Brazil Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 61. Argentina Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 62. Argentina Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 63. Rest of South and Central America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 64. Rest of South and Central America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 65. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 66. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 67. Glossary of Terms, Sarcopenia Treatment Market

LIST OF FIGURES

Figure 1. Sarcopenia Treatment Market Segmentation, By Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Sarcopenia Treatment Market Breakdown by Geography, 2022 and 2030 (%)
Figure 5. Sarcopenia Treatment Market Revenue (US$ Million), 2022 – 2030
Figure 6. Sarcopenia Treatment Market Share (%) – By Treatment Type, 2022 and 2030
Figure 7. Vitamin D and Calcium Supplement Market Revenue and Forecasts To 2030 (US$ Million)
Figure 8. Protein Supplement Market Revenue and Forecasts To 2030 (US$ Million)
Figure 9. Vitamin B12 Supplement Market Revenue and Forecasts To 2030 (US$ Million)
Figure 10. Others Market Revenue and Forecasts To 2030 (US$ Million)
Figure 11. Sarcopenia Treatment Market Share (%) – By Distribution Channel, 2022 and 2030
Figure 12. Pharmacies Market Revenue and Forecasts To 2030 (US$ Million)
Figure 13. Retail Channels Market Revenue and Forecasts To 2030 (US$ Million)
Figure 14. Online Channels Market Revenue and Forecasts To 2030 (US$ Million)
Figure 15. Others Market Revenue and Forecasts To 2030 (US$ Million)
Figure 16. Sarcopenia Treatment Market Breakdown by Region, 2022 and 2030 (%)
Figure 17. North America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 18. North America Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
Figure 19. North America Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
Figure 20. North America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 21. United States Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 22. Canada Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 23. Mexico Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 24. Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 25. Europe Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
Figure 26. Europe Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
Figure 27. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 28. Germany Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 29. France Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 30. United Kingdom Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 31. Italy Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 32. Spain Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 33. Rest of Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 34. Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 35. Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
Figure 36. Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
Figure 37. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 38. China Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 39. India Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 40. Japan Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 41. South Korea Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 42. Australia Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 43. Rest of APAC Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 44. Middle East and Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 45. Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
Figure 46. Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
Figure 47. Middle East and Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 48. South Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 49. Saudi Arabia Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 50. United Arab Emirates Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 51. Rest of Middle East and Africa Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 52. South and Central America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 53. South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
Figure 54. South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
Figure 55. South and Central America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 56. Brazil Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 57. Argentina Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 58. Rest of South and Central America Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 59. Growth Strategies in the Sarcopenia Treatment Market

The List of Companies – Sarcopenia Treatment Market
– Abbott Laboratories          
– Bayer AG               
– Metagenics LLC   
– Nestle Health Science SA                
– Novartis AG          
– Pfizer Inc                
– Sanofi SA               
– Amway Corp        
– GSK Plc   
– Makers Nutrition LLC 

Reviews

There are no reviews yet.

Be the first to review “Sarcopenia Treatment Market Size and Forecasts (2020 – 2030)”